ACLY and cardiovascular disorder: The method was recently implemented in a study of ACLY and cardiovascular disease which incorporated multiple germline genetic variants (IVs) to construct GS as single IV and further inferred the causal relationship between ACLY inhibitors and the reduced risk of cardiovascular disease (Ference et al., 2019).